Antimicrobial Stewardship in U.S. Hospitals: A Work in Progress

Deviation from recommended practices occurred for most patients who received antibiotics for CAP or UTI or who were prescribed fluoroquinolones or vancomycin.

Rising antimicrobial resistance has spawned U.S. hospital stewardship programs aimed at guiding prescription practices supported by disease-state treatment standards plus documentation of clinical and microbiological evidence of infection. Researchers analyzed prevalence surveys of antimicrobial use in a cross-sectional sample encompassing 1566 patients at 192 hospitals in 10 states. Cases encompassed community-acquired pneumonia (CAP), urinary tract infection (UTI), fluoroquinolone treatment (FQ), or intravenous vancomycin treatment (VAN). Patients were evaluated for supported or unsupported antimicrobial use based on medical record data (signs and symptoms of infection, microbiology test results, antimicrobial treatment duration, deviatio…

Reviewing Author

George Sakoulas, MD

Disclosures

Consultant/Advisory BoardParatek Pharmaceuticals; Nestle Corp.; AbbVie; Shionogi

Speaker’s BureauAllergan/AbbVie; Paratek Pharmaceuticals; Nestle Corp.

RoyaltiesUpToDate

Editorial BoardsAntimicrobial Agents and Chemotherapy; Open Forum Infectious Diseases

George Sakoulas, MD

Disclosures

Consultant/Advisory BoardParatek Pharmaceuticals; Nestle Corp.; AbbVie; Shionogi

Speaker’s BureauAllergan/AbbVie; Paratek Pharmaceuticals; Nestle Corp.

RoyaltiesUpToDate

Editorial BoardsAntimicrobial Agents and Chemotherapy; Open Forum Infectious Diseases

Antimicrobial Stewardship in U.S. Hospitals: A Work in Progress

Topics

Reviewing Author